Marinus Pharmaceuticals, Inc.【MRNS】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
3Q24 -670,600 +26.5%
2Q24 -646,400 +30.0%
1Q24 -610,600 +31.2%
4Q23 -571,900 +32.8%
3Q23 -530,200 +33.8%
2Q23 -497,200 +5.9%
1Q23 -465,300 +8.2%
4Q22 -430,500 +4.8%
3Q22 -396,200 +3.6%
2Q22 -469,500 +29.4%
1Q22 -430,100 +26.8%
4Q21 -410,700 +31.7%
3Q21 -382,400 +29.8%
2Q21 -362,900 +30.2%
1Q21 -339,100 +28.9%
4Q20 -311,900 +32.4%
3Q20 -294,500 +33.7%
2Q20 -278,800 +35.1%
1Q20 -263,100 +35.7%
4Q19 -235,574 +29.8%
3Q19 -220,200 +28.5%
2Q19 -206,400 +28.8%
1Q19 -193,900 +28.6%
4Q18 -181,453 +25.4%
3Q18 -171,341 +22.4%
2Q18 -160,231 +18.0%
1Q18 -150,726 +14.8%
4Q17 -144,727 +15.0%
3Q17 -139,989 +16.8%
2Q17 -135,819 +19.8%
1Q17 -131,267 +25.7%
4Q16 -125,829 +29.5%
3Q16 -119,814 +33.8%
2Q16 -113,351 +34.0%
1Q16 -104,402 +31.6%
4Q15 -97,186 +34.4%
3Q15 -89,573 +30.3%
2Q15 -84,611 -
1Q15 -79,343 -
4Q14 -72,336 -
3Q14 -68,730 -